| Understanding intellectual disability and autism spectrum disorders from common mouse models: synapses to behaviour V Verma, A Paul, A Amrapali Vishwanath, B Vaidya, JP Clement Open biology 9 (6), 180265, 2019 | 57 | 2019 |
| Parkinson's disease in women: mechanisms underlying sex differences B Vaidya, K Dhamija, P Guru, SS Sharma European journal of pharmacology 895, 173862, 2021 | 44 | 2021 |
| Therapeutic potential of pharmacological agents targeting TRP channels in CNS disorders P Thapak, B Vaidya, HC Joshi, JN Singh, SS Sharma Pharmacological research 159, 105026, 2020 | 34 | 2020 |
| Transient receptor potential channels as an emerging target for the treatment of Parkinson’s disease: an insight into role of pharmacological interventions B Vaidya, SS Sharma Frontiers in Cell and Developmental Biology 8, 584513, 2020 | 29 | 2020 |
| Pharmacological modulation of TRPM2 channels via PARP pathway leads to neuroprotection in MPTP-induced Parkinson’s disease in Sprague dawley rats B Vaidya, H Kaur, P Thapak, SS Sharma, JN Singh Molecular Neurobiology 59 (3), 1528-1542, 2022 | 26 | 2022 |
| Gut microbiota in mental health and depression: Role of pre/pro/synbiotics in their modulation HN Methiwala, B Vaidya, VK Addanki, M Bishnoi, SS Sharma, ... Food & Function 12 (10), 4284-4314, 2021 | 24 | 2021 |
| Neuroprotective potential of caffeic acid phenethyl ester (CAPE) in CNS disorders: mechanistic and therapeutic insights NP Kulkarni, B Vaidya, AS Narula, SS Sharma Current Neuropharmacology 19 (9), 1401, 2021 | 20 | 2021 |
| Chemogenetic activation of excitatory neurons alters hippocampal neurotransmission in a dose-dependent manner S Pati, SS Salvi, M Kallianpur, B Vaidya, A Banerjee, S Maiti, JP Clement, ... Eneuro 6 (6), 2019 | 18 | 2019 |
| Combination of peroxisome proliferator-activated receptor Gamma (PPARγ) agonist and PPAR Gamma co-activator 1α (PGC-1α) activator ameliorates cognitive deficits, oxidative … NR Das, B Vaidya, P Khare, M Bishnoi, SS Sharma Current Neurovascular Research 18 (5), 497-507, 2021 | 17 | 2021 |
| Bifidobacterium breve bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouse G Sushma, B Vaidya, S Sharma, G Devabattula, M Bishnoi, ... Neuropharmacology 229, 109480, 2023 | 6 | 2023 |
| Neuroprotective Potential of HC070, a Potent TRPC5 Channel Inhibitor in Parkinson′ s Disease Models: A Behavioral and Mechanistic Study B Vaidya, I Roy, SS Sharma ACS Chemical Neuroscience 13 (18), 2728-2742, 2022 | 6 | 2022 |
| Understanding intellectual disability and autism spectrum disorders from common mouse models: synapses to behaviour. Open Biol. 2019; 9 (6): 180265 V Verma, A Paul, AA Vishwanath, B Vaidya, JP Clement | 6 | |
| Fused human paraoxonase 1 as a prophylactic agent against organophosphate poisoning P Dobariya, P Adhya, B Vaidya, PY Khandave, SS Sharma, AH Pande Enzyme and microbial technology 165, 110209, 2023 | 4 | 2023 |
| Amelioration of Parkinson's disease by pharmacological inhibition and knockdown of redox sensitive TRPC5 channels: Focus on mitochondrial health B Vaidya, P Gupta, JK Laha, I Roy, SS Sharma Life Sciences 328, 121871, 2023 | 3 | 2023 |
| 2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP/MPP+ model of Parkinson’s disease B Vaidya, M Polepalli, SS Sharma, JN Singh Mitochondrion 69, 95-103, 2023 | 3 | 2023 |
| Caffeic acid phenethyl ester (CAPE) attenuates paclitaxel-induced peripheral neuropathy: a mechanistic study NP Kulkarni, B Vaidya, AS Narula, SS Sharma Current Neurovascular Research 19 (3), 293-302, 2022 | 3 | 2022 |
| BTD: A TRPC5 activator ameliorates mechanical allodynia in diabetic peripheral neuropathic rats by modulating TRPC5-CAMKII-ERK pathway P Adhya, B Vaidya, SS Sharma Neurochemistry International 170, 105609, 2023 | 2 | 2023 |
| Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role R Tyagi, B Vaidya, SS Sharma Pharmacological Reports 74 (5), 790-817, 2022 | 2 | 2022 |
| Supplementation of probiotic Bifidobacterium breve Bif11 reverses neurobehavioural deficits, inflammatory changes and oxidative stress in Parkinson's disease model S Valvaikar, B Vaidya, S Sharma, M Bishnoi, KK Kondepudi, SS Sharma Neurochemistry International, 105691, 2024 | 1 | 2024 |
| Ion Channels and Metal Ions in Parkinson’s Disease: Historical Perspective to the Current Scenario B Vaidya, DS Padhy, HC Joshi, SS Sharma, JN Singh Neuroprotection: Method and Protocols, 529-557, 2024 | | 2024 |
Shyam S. SharmaProfessor-Pharmacology & Toxicology, NIPER MohaliVerified email at niper.ac.in
